- 7/24 Live Call Center
Prof. Dr. Tülin Tıraje Celkan is an internationally renowned expert in pediatric hematology and oncology, celebrated for her extraordinary contributions to both scientific research and clinical excellence. With nearly three decades of dedicated practice, Dr. Celkan has become a beacon of hope for families and patients around the world who seek proven expertise and life-changing outcomes in the treatment of childhood blood disorders and cancers.
At the heart of Dr. Celkan’s distinguished career is her unwavering commitment to evidence-based, patient-focused medicine. As a trailblazer in her field, she combines the most advanced diagnostic and therapeutic tools with a deep compassion for her patients, ensuring every child receives personalized care tailored to their unique medical and emotional needs. Her expertise spans the diagnosis and management of complex conditions including childhood leukemias, anemias, lymphomas, hemangiomas, and rare blood diseases—where treatment precision can make a profound impact on outcomes and quality of life.
Dr. Celkan’s reputation as a scientific leader extends far beyond her clinical practice. She has played a pivotal role in advancing pediatric care through groundbreaking research, serving as principal investigator in international studies on rare factor deficiencies, plasminogen deficiency, and innovative treatment methodologies. Her prolific academic output includes over 130 scientific studies indexed in PubMed, multiple book chapters in international medical texts, and an impressive 2,740+ citations on Google Scholar—testaments to her global influence and respected voice among peers.
Recognizing the importance of nurturing the next generation of medical professionals, Prof. Dr. Celkan is also a passionate educator and mentor. She has supervised a wealth of academic theses on childhood hematological malignancies and blood disorders, fostering a culture of research-driven, high-standard pediatric care. Her leadership has helped shape the curricula at some of Turkey’s top medical institutions, including the Cerrahpaşa Faculty of Medicine, and empowered dozens of future pediatricians and scientists.
Dr. Celkan’s commitment to continuous learning and collaboration is further highlighted by her active roles in esteemed organizations such as the Turkish Hematology Association, Turkish Pediatric Hematology Association, Turkish Pediatric Oncology Association, and the International Society of Pediatric Oncology (SIOP). As a global thought leader, she collaborates with experts worldwide to establish and uphold the highest standards of care and research in pediatric hematology and oncology.
Dr. Tülin Tıraje Celkan’s excellence in medicine is demonstrated by her substantial academic output—more than 130 PubMed-indexed studies and thousands of citations in the scientific community—as well as her leadership in landmark research projects on rare pediatric blood disorders. She has shaped national and international standards through authored book chapters, editorial roles, and the supervision of numerous postgraduate theses. Her clinical insights and evidence-based practices directly inform advances in pediatric hematology and oncology, earning the trust of colleagues, families, and young patients alike. Dr. Celkan’s distinguished career continues to set new benchmarks in compassionate care, scientific discovery, and the global advancement of children’s health.
Prof. Dr. Tülin Tıraje Celkan is an internationally renowned expert in pediatric hematology and oncology, celebrated for her extraordinary contributions to both scientific research and clinical excellence. With nearly three decades of dedicated practice, Dr. Celkan has become a beacon of hope for families and patients around the world who seek proven expertise and life-changing outcomes in the treatment of childhood blood disorders and cancers.
At the heart of Dr. Celkan’s distinguished career is her unwavering commitment to evidence-based, patient-focused medicine. As a trailblazer in her field, she combines the most advanced diagnostic and therapeutic tools with a deep compassion for her patients, ensuring every child receives personalized care tailored to their unique medical and emotional needs. Her expertise spans the diagnosis and management of complex conditions including childhood leukemias, anemias, lymphomas, hemangiomas, and rare blood diseases—where treatment precision can make a profound impact on outcomes and quality of life.
Dr. Celkan’s reputation as a scientific leader extends far beyond her clinical practice. She has played a pivotal role in advancing pediatric care through groundbreaking research, serving as principal investigator in international studies on rare factor deficiencies, plasminogen deficiency, and innovative treatment methodologies. Her prolific academic output includes over 130 scientific studies indexed in PubMed, multiple book chapters in international medical texts, and an impressive 2,740+ citations on Google Scholar—testaments to her global influence and respected voice among peers.
Recognizing the importance of nurturing the next generation of medical professionals, Prof. Dr. Celkan is also a passionate educator and mentor. She has supervised a wealth of academic theses on childhood hematological malignancies and blood disorders, fostering a culture of research-driven, high-standard pediatric care. Her leadership has helped shape the curricula at some of Turkey’s top medical institutions, including the Cerrahpaşa Faculty of Medicine, and empowered dozens of future pediatricians and scientists.
Dr. Celkan’s commitment to continuous learning and collaboration is further highlighted by her active roles in esteemed organizations such as the Turkish Hematology Association, Turkish Pediatric Hematology Association, Turkish Pediatric Oncology Association, and the International Society of Pediatric Oncology (SIOP). As a global thought leader, she collaborates with experts worldwide to establish and uphold the highest standards of care and research in pediatric hematology and oncology.
Dr. Tülin Tıraje Celkan’s excellence in medicine is demonstrated by her substantial academic output—more than 130 PubMed-indexed studies and thousands of citations in the scientific community—as well as her leadership in landmark research projects on rare pediatric blood disorders. She has shaped national and international standards through authored book chapters, editorial roles, and the supervision of numerous postgraduate theses. Her clinical insights and evidence-based practices directly inform advances in pediatric hematology and oncology, earning the trust of colleagues, families, and young patients alike. Dr. Celkan’s distinguished career continues to set new benchmarks in compassionate care, scientific discovery, and the global advancement of children’s health.
Research:
Publications:
